WallStreetZenWallStreetZen

NASDAQ: AVXL
Anavex Life Sciences Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their AVXL stock forecasts and price targets.

Forecast return on equity

Is AVXL forecast to generate an efficient return?

Company
391.83%
Industry
20.4%
Market
169.83%
AVXL's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is AVXL forecast to generate an efficient return on assets?

Company
366.75%
Industry
23.7%
AVXL is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

AVXL earnings per share forecast

What is AVXL's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.56
Avg 2 year Forecast
$2.32
Avg 3 year Forecast
$4.75

AVXL revenue forecast

What is AVXL's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$74.5M
Avg 2 year Forecast
$355.5M
Avg 3 year Forecast
$727.3M

AVXL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
AVXL$1.48N/AN/A
OTLK$0.56$5.37+851.60%Buy
IPHA$1.47$8.00+444.22%Strong Buy
ANTX$3.60$9.00+150.00%Strong Buy
ALXO$0.98N/AN/A
View Top Biotech Stocks

Anavex Life Sciences Stock Forecast FAQ

What is AVXL's earnings growth forecast for 2027-2029?

(NASDAQ: AVXL) Anavex Life Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.43%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.27%.

Anavex Life Sciences's earnings in 2026 is -$13,022,000.On average, 3 Wall Street analysts forecast AVXL's earnings for 2027 to be -$52,002,928, with the lowest AVXL earnings forecast at -$49,963,598, and the highest AVXL earnings forecast at -$53,532,426. On average, 3 Wall Street analysts forecast AVXL's earnings for 2028 to be $214,630,268, with the lowest AVXL earnings forecast at $206,213,395, and the highest AVXL earnings forecast at $220,942,923.

In 2029, AVXL is forecast to generate $440,606,629 in earnings, with the lowest earnings forecast at $423,327,938 and the highest earnings forecast at $453,565,648.

If you're new to stock investing, here's how to buy Anavex Life Sciences stock.

What is AVXL's revenue growth forecast for 2027-2029?

(NASDAQ: AVXL) Anavex Life Sciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 30.42%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.03%.

Anavex Life Sciences's revenue in 2026 is $0.On average, 3 Wall Street analysts forecast AVXL's revenue for 2027 to be $6,902,206,855, with the lowest AVXL revenue forecast at $6,631,532,077, and the highest AVXL revenue forecast at $7,105,212,939. On average, 3 Wall Street analysts forecast AVXL's revenue for 2028 to be $32,957,435,205, with the lowest AVXL revenue forecast at $31,665,241,227, and the highest AVXL revenue forecast at $33,927,044,172.

In 2029, AVXL is forecast to generate $67,420,267,123 in revenue, with the lowest revenue forecast at $64,775,626,221 and the highest revenue forecast at $69,403,052,574.

What is AVXL's forecast return on assets (ROA) for 2027-2029?

(NASDAQ: AVXL) forecast ROA is 366.75%, which is higher than the forecast US Biotechnology industry average of 23.7%.

What is AVXL's Earnings Per Share (EPS) forecast for 2027-2029?

(NASDAQ: AVXL) Anavex Life Sciences's current Earnings Per Share (EPS) is -$0.15. On average, analysts forecast that AVXL's EPS will be -$0.56 for 2027, with the lowest EPS forecast at -$0.54, and the highest EPS forecast at -$0.58. On average, analysts forecast that AVXL's EPS will be $2.32 for 2028, with the lowest EPS forecast at $2.22, and the highest EPS forecast at $2.38. In 2029, AVXL's EPS is forecast to hit $4.75 (min: $4.57, max: $4.89).

What is AVXL's forecast return on equity (ROE) for 2027-2029?

(NASDAQ: AVXL) forecast ROE is 391.83%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.